ICLR vs MEDP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

ICLR

30.9
AI Score
VS
MEDP Wins

MEDP

53.9
AI Score

Investment Advisor Scores

ICLR

31score
Recommendation
AVOID NEW MONEY

MEDP

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ICLR MEDP Winner
Forward P/E 18.2482 34.1297 ICLR
PEG Ratio 0.5716 3.4591 ICLR
Revenue Growth -2.9% 8.5% MEDP
Earnings Growth -63.3% 25.4% MEDP
Tradestie Score 30.9/100 53.9/100 MEDP
Profit Margin 5.3% 18.2% MEDP
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD MEDP

Relative Price Performance (Last 90 Days)

ICLR 1M: +21.5% · 3M: +19.2% MEDP 1M: +9.0% · 3M: +14.2%

Current Technical Phase

ICLR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 58

RSI (14): 58.3 · Price: $199.70

MEDP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.7% over 20 days), RSI 56

RSI (14): 55.9 · Price: $664.77

Fundamentals Snapshot

Metric ICLR MEDP
Market Cap — —
Forward P/E 17.2 33.5
Trailing P/E 81.9 36.9
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.7%
Operating Margin 0.1% 0.2%
EPS 2.50 18.01
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MEDP is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.